...
首页> 外文期刊>Journal of Controlled Release: Official Journal of the Controlled Release Society >New microemulsion vehicle facilitates percutaneous penetration in vitro and cutaneous drug bioavailability in vivo
【24h】

New microemulsion vehicle facilitates percutaneous penetration in vitro and cutaneous drug bioavailability in vivo

机译:新型微乳液车辆有助于在体内体外经皮和皮肤药物生物利用度进行经皮渗透

获取原文
获取原文并翻译 | 示例

摘要

Microemulsion systems possessing a potentially improved skin bioavailability of lidocaine were designed and explored for some characteristics. The existence of microemulsion regions was investigated in quaternary systems composed of glyceryl oleate+polyoxyl 40 fatty acid derivatives (surfactants)/tetraglycol (co-surfactant)/isopropyl palmitate/water by constructing pseudo-ternary phase diagrams at fixed co-surfactant/surfactants (CoS/S) ratios. Light scattering measurements used to determine the diameter of the internal phase revealed that lidocaine in the microemulsions increased the droplet size, implying a drug tendency to accumulate in the interfacial layers. Percutancous penetration studies using rat skin in vitro showed that the transdermal flux of lidocaine was significantly improved by microemulsion composed of the glyceryl oleate-PEG-40 stearate combination rather than glyceryl oleate-PEG-40 hydroxylated castor oil. Two principal factors were found to govern the transdermal penetration of lidocame from the microemulsion: water content and the CoS/S ratio. By analyzing skin layers (epidermis and dermis) for lidocaine content, significantly higher concentrations were found after rats were treated in vivo with liquid microemulsions (CoS/S = 1.8, 30 wt.% water) or patches compared to those measured after application of EMLA cream. It has been suggested, therefore, that these microemulsions loaded with lidocaine would provide adequate analgesia in relatively shorter periods of time. (C) 2004 Elsevier B.V. All rights reserved.
机译:设计并探索了具有利多卡因的潜在提高皮肤生物利用度的微乳液系统,以实现一些特征。通过在固定的共表面活性剂/表面活性剂构建伪三元相图( COS / s)比率。用于确定内部相直径的光散射测量显示,微乳液中的利多卡因增加了液滴尺寸,这意味着在界面层中积聚的药物倾向。通过体外大鼠皮肤的Percutancous渗透性研究表明,通过微乳液组成的微乳液组成的微乳液的透皮通量显着提高了糖糖醇-PEG-40硬脂酸酯组合而不是甘露出剂-PEG-40羟基化蓖麻油。发现两个主要因素治理LIDOMAME从微乳液中的透皮渗透:含水量和COS / S比率。通过分析用于利多卡因含量的皮肤层(表皮和真皮),与液体微乳液(COS / S = 1.8,30重量%的水)或贴剂相比,在体内处理大鼠后发现大鼠的浓度明显较高奶油。因此,已经提出了用利多卡因装载的这些微乳液将在相对较短的时间段内提供足够的镇痛。 (c)2004年elestvier b.v.保留所有权利。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号